Novel Recursive Partitioning Analysis Classification for Newly Diagnosed Glioblastoma: A Multi-Institutional Study Highlighting the MGMT Promoter Methylation and IDH1 Gene Mutation Status

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2017.06.871
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Personalized Treatment Strategies in Glioblastoma: MGMT Promoter Methylation Status

OncoTargets and Therapy
OncologyPharmacology
2013English

Prognostic or Predictive Value of MGMT Promoter Methylation in Gliomas Depends on IDH1 Mutation

Neurology
Neurology
2013English

The Predictive but Not Prognostic Value of MGMT Promoter Methylation Status in Elderly Glioblastoma Patients: A Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Validation and Simplification of the Radiation Therapy Oncology Group Recursive Partitioning Analysis Classification for Glioblastoma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2011English

MGMT Methylation Status: The Advent of Stratified Therapy in Glioblastoma?

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2007English

Prognostic Value of MGMT Promoter Methylation in Glioblastoma Patients Treated With Temozolomide-Based Chemoradiation: A Portuguese Multicentre Study

Oncology Reports
MedicineCancer ResearchOncology
2010English

Continuing the Search for MR Imaging Biomarkers for MGMT Promoter Methylation Status: Conventional and Perfusion MRI Revisited

Neuroradiology
Nuclear MedicineRadiologyCardiologyNeurologyCardiovascular MedicineImaging
2011English

Local Recurrence After Surgery for Non–small Cell Lung Cancer: A Recursive Partitioning Analysis of Multi-Institutional Data

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2013English

MGMT Promoter Methylation Cutoff With Safety Margin for Selecting Glioblastoma Patients Into Trials Omitting Temozolomide. A Pooled Analysis of Four Clinical Trials.

Clinical Cancer Research
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy